Rockefeller Capital Management »

Humacyte shares owned by Rockefeller Capital Management

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Rockefeller Capital Management from 13F filings

Historical chart of Rockefeller Capital Management investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Rockefeller Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $469 270 1.74
2025-03-31 $631k 370k 1.71
2024-12-31 $251k 50k 5.05

More positions owned by Rockefeller Capital Management

Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
salesforce (CRM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Tidal Trust Iii Rockefeller Glob (RGEF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Tidal Trust Iii Rockefeller Us S (RSMC)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Rockefeller Capital Management

Top funds holding Humacyte

BlackRock
Vanguard Group
Geode Capital Management
State Street Corporation
UBS Group
Woodline Partners
Susquehanna International
Morgan Stanley
Two Sigma Investments
Millennium Management
Citadel Advisors
Northern Trust
Private Advisor
Charles Schwab Investment Management
Marshall Wace

View all funds holding Humacyte